CEFOTAXIME NORIDEM 0.5 g, powder for solution for injection/for infusion 10 bottles of 0.5 g
Active ingredients: Cefotaxime, Cefotaxime sodium
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injection or infusion10 bottles of 0.5 gintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CEFOTAXIME NORIDEM 0,5 g, poudre pour solution injectable/pour perfusion
- Pharmaceutical form
- poudre pour solution injectable ou pour perfusion
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 10 flacon(s) en verre de 0,5 g
- Marketing authorisation holder
- NORIDEM ENTREPRISES LIMITED (CHYPRE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 18 May 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68400129CIP73020548CIP133400930205488Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉFOTAXIME SODIQUEpoudre | — | SA |
| CÉFOTAXIMEpoudre | 0,5 g · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.